Peterson Kristine 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Peterson Kristine
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-13+15,700→ 15,700 totalExercise: $6.83Exp: 2035-03-13→ Common Stock (15,700 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 13, 2025), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2026 annual meeting of stockholders.